Context Therapeutics Inc. · NASDAQ:CNTX
Avidity Partners Management LP's stake in Context Therapeutics Inc. fell to 9.90% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Avidity Partners Management LP's stake in Context Therapeutics Inc. fell to 9.90%, 7,494,011 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 7,494,011
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avidity Partners Management LP | 9.90% | 7,494,011 |
| Avidity Partners Management (GP) LLC | 9.90% | 7,494,011 |
| Avidity Capital Partners Fund (GP) LP | 9.90% | 7,494,011 |
| Avidity Capital Partners (GP) LLC | 9.90% | 7,494,011 |
| Avidity Master Fund LP | 6.70% | 5,183,645 |
| Avidity Private Master Fund I LP | 9.90% | 7,776,296 |
| David Witzke | 0% | 0 |
| Michael Gregory | 9.90% | 7,494,011 |
Source
Related
- Context Therapeutics Inc.
- Avidity Partners Management LP
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Avidity Partners Management LP · May 12, 2026
- Schedule 13G/A · Avidity Partners Management LP · Nov 14, 2025
- Schedule 13G/A · Avidity Partners Management LP · Aug 14, 2025
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026